Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;35(3):113-134.
doi: 10.1007/s40211-021-00395-9. Epub 2021 Jun 23.

Practitioner's review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions

Christian Popow  1 , Susanne Ohmann  2 , Paul Plener  2
Affiliations
Review

Practitioner's review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions

Christian Popow et al. Neuropsychiatr. 2021 Sep.

Abstract
in English, German

Alleviating the multiple problems of children with autism spectrum disorder (ASD) and its comorbid conditions presents major challenges for the affected children, parents, and therapists. Because of a complex psychopathology, structured therapy and parent training are not always sufficient, especially for those patients with intellectual disability (ID) and multiple comorbidities. Moreover, structured therapy is not available for a large number of patients, and pharmacological support is often needed, especially in those children with additional attention deficit/hyperactivity and oppositional defiant, conduct, and sleep disorders.

Die Linderung der vielfältigen Probleme von Kindern mit Autismus-Spektrum-Störung (ASS) und ihrer Begleiterkrankungen stellt für die betroffenen Kinder, Eltern und Therapeuten eine große Herausforderung dar. Aufgrund einer komplexen Psychopathologie reichen strukturierte Therapie und Elterntraining nicht immer aus, insbesondere bei Menschen mit geistiger Behinderung (GB) und multiplen Komorbiditäten. Darüber hinaus steht für viele Patienten keine strukturierte Therapie zur Verfügung, und häufig ist pharmakologische Unterstützung erforderlich, insbesondere bei Kindern, bei denen eine Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung und oppositionelle Trotz‑, Verhaltens- oder Schlafstörungen hinzukommen.

Keywords: ADHD; Autism spectrum disorder; Children and adolescents; Pharmacotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors state that no author has a conflict of interest to declare.

Figures

Fig. 1
Fig. 1
Processing of records
See this image and copyright information in PMC

References

    1. Aadil M, Cosme RM, Chernaik J. Mindfulness-based cognitive behavioral therapy as an adjunct treatment of Attention Deficit Hyperactivity disorder in young adults: A literature review. Cureus. 2017;9(5):e1269. doi: 10.7759/cureus.1269. - DOI - PMC - PubMed
    1. Agarwal R, Burke SL, Maddux M. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. BMC Psychiatry. 2019;19(328):1–10. doi: 10.1186/s12888-019-2259-4. - DOI - PMC - PubMed
    1. Allen A, Kurlan R, Gilbert D, Dunn D, Dallee FR, Spencer T. 16th World Congress of IACAPAP. Darmstadt: Steinkopff; 2004. Atomoxetine treatment in children with ADHD and comorbid tic disorders; pp. 311–331.
    1. Aman MG, Buican B, Arnold LE. Methylphenidate treatmentin children with borderline IQ and mental retardation: analysis of three aggregated studies. J Child Adolesc Psychopharmacol. 2003;13(1):29–40. doi: 10.1089/104454603321666171. - DOI - PubMed
    1. Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, Hyman SL, Mendoza-Burcham M, Pan X, Mruzek DW, Lecavalier L, Levato L, Silverman LB, Handen B. A review of atomoxetine effects in young people with developmental disabilities. Res Dev Disabil. 2014;35(6):1412–1424. doi: 10.1016/j.ridd.2014.03.006. - DOI - PMC - PubMed

MeSH terms